Is Pfizer Stock a Buy Now?
A year ago, (NYSE: PFE) was soundly beating the market, racking up highly impressive sales thanks to its COVID-19 products. But with the pandemic no longer a global health crisis per guidance from the World Health Organization (WHO), this market has become substantially less lucrative for the pharma giant.
That's why Pfizer's shares are already down by 21% year to date, even as broader equities roar back following a downturn. The market is forward-looking, so this may be a clue that Pfizer's prospects aren't all that appealing. Or perhaps, in this case, it isn't looking forward enough, and Pfizer is a steal at current levels.
Which is it? Let's dig in and find out.
Source Fool.com
Pfizer Inc. Stock
€28.43
0.300%
With 28 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 41 € there is a positive potential of 44.21% for Pfizer Inc. compared to the current price of 28.43 €.
